The Pennant Group, Inc. (PNTG) reported $209.84 million in revenue for the quarter ended March 2025, representing a year-over-year increase of 33.7%. EPS of $0.27 for the same period compares to $0.20 a year ago.The reported revenue represents a surprise of +3.68% over the Zacks Consensus Estimate of $202.4 million. With the consensus EPS estimate being $0.22, the EPS surprise was +22.73%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _____________________________ FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended March 31, 2025. ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the transition period from to . Commission file number: 001-38900 __________________________ THE PENNANT GROUP, INC. (Exact Name of Registrant as Specified in Its Cha ...

Exhibit 99.1 Pennant Reports First Quarter 2025 Results Conference Call and Webcast scheduled for tomorrow, May 7, 2025 at 10:00 am MT EAGLE, Idaho – May 6, 2025 (GLOBE NEWSWIRE) - The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, today announced its operating results, reporting GAAP diluted earnings per share of $0.22 for the first quarter of 2025. Pennant also reported adjusted diluted earnings per share of $0.27 ...

Core Viewpoint - The Pennant Group, Inc. reported strong operating results for the first quarter of 2025, with significant increases in revenue, net income, and adjusted earnings per share, indicating positive momentum across its home health, hospice, and senior living segments [1][4][5]. Financial Performance - Total revenue for Q1 2025 was $209.8 million, a 33.7% increase from $156.9 million in Q1 2024 [4][19]. - Net income for Q1 2025 was $7.8 million, up 58.5% from $5.1 million in Q1 2024 [4][12]. - Adjusted net income for Q1 2025 was $9.6 million, reflecting a 61.4% increase from $5.9 million in Q1 2024 [4][30]. - GAAP diluted earnings per share were $0.22, compared to $0.16 in the prior year [1][12]. - Adjusted diluted earnings per share were $0.27, up from $0.20 in Q1 2024 [1][30]. Segment Performance - Home Health and Hospice Services segment revenue was $159.9 million, a 37.2% increase from $116.5 million in Q1 2024 [4][19]. - Senior Living Services segment revenue reached $50.0 million, a 23.6% increase from $40.4 million in Q1 2024 [4][24]. - Total home health admissions increased by 28.9% to 18,878, while Medicare home health admissions rose by 19.7% to 7,599 [4][22]. - Hospice average daily census increased by 28.1% to 3,794 [4][22]. - Senior Living average monthly revenue per occupied room increased by 11.3% to $5,193 [4][24]. Operational Highlights - Consolidated Adjusted EBITDAR for Q1 2025 was $28.0 million, a 31.0% increase from $21.4 million in Q1 2024 [4][35]. - Consolidated Adjusted EBITDA for Q1 2025 was $16.4 million, reflecting a 45.9% increase from $11.2 million in Q1 2024 [4][35]. - The company emphasized ongoing investments in leadership development as a key driver of operational success [4][5]. Future Outlook - The company plans to discuss its financial results in a live webcast scheduled for May 7, 2025, indicating a commitment to transparency and investor engagement [1][6].

Shares of The Pennant Group, Inc. (PNTG) have gained 1.6% over the past four weeks to close the last trading session at $25.82, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $33.20 indicates a potential upside of 28.6%.The mean estimate comprises five short-term price targets with a standard deviation of $4.32. While the lowest estimate of $28 indicates an 8.4% increase from t ...

EAGLE, Idaho, April 21, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of operating subsidiaries that provide home health, hospice and senior living services, announced today that it expects to issue its first quarter 2025 financial results on Tuesday, May 6, 2025. Pennant invites current and prospective investors to tune into a live webcast to be held the following day, Wednesday, May 7, 2025, at 10:00 a.m. Mountain Time (12:00 p.m. Eastern Time), during which Pennant’s ...

EAGLE, Idaho, April 01, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ:PNTG), the parent company of the Pennant group of affiliated home health, hospice, home care and senior living companies, announces the acquisition of the real estate and operations of an established senior living community in Arizona. The newly acquired community offers assisted living and memory care services, and increases Pennant's Arizona operations by 128 units. "This acquisition aligns with our mission to provide life-ch ...

EAGLE, Idaho, April 01, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice, home care and senior living companies, announces the acquisition of the real estate and operations of an established senior living community in Arizona. The newly acquired community offers assisted living and memory care services, and increases Pennant's Arizona operations by 128 units. "This acquisition aligns with our mission to provide life-c ...

Core Points - The Pennant Group, Inc. will participate in the 2025 Oppenheimer Co. Annual Healthcare MedTech & Services Conference on March 18, 2025 [1] - Key executives including the CEO, CFO, and Executive Vice President will engage in a fireside chat during the conference [2] Company Overview - The Pennant Group, Inc. operates as a holding company for independent subsidiaries providing healthcare services through 131 home health and hospice agencies and 60 senior living communities across various states [3] - Each subsidiary operates independently with its own management, employees, and assets, indicating a decentralized operational structure [3]

Financial Data and Key Metrics Changes - The company reported Q4 adjusted earnings per share of $0.24, contributing to a full year adjusted earnings per share of $0.94, exceeding the updated guidance midpoint of $0.93 [11] - Full year consolidated revenue reached $695.2 million, an increase of $150.3 million or 27.6% over the prior year, with adjusted EBITDA of $53.3 million, an improvement of $12.6 million or 30.9% [12][33] - The company generated $20.6 million in net cash from operating activities and $17.2 million in free cash flow during Q4 [36] Business Line Data and Key Metrics Changes - Home health and hospice segment revenue for the full year increased to $519.5 million, a $125 million or 31.7% increase over the prior year, with Q4 revenue at $142 million, a $35.1 million or 32.9% increase [21] - Senior living segment revenue improved to $175.8 million, an increase of $25.3 million or 16.8% over the prior year, with Q4 revenue at $46.9 million, a $7.8 million or 20% increase [26] Market Data and Key Metrics Changes - Home health admissions reached a new high of 15,909, an increase of 40.9%, while Medicare admissions increased to 6,443, a 30.1% rise [22] - The average CMS-reported star rating was 4.1, significantly exceeding the national average of 3.0, indicating strong clinical outcomes [24] Company Strategy and Development Direction - The company is focused on five key initiatives: leadership development, employee experience, clinical excellence, margin, and growth, with significant progress made in each area [14] - The company anticipates full-year 2025 revenue in the range of $800 million to $865 million, with adjusted earnings per share projected between $1.03 and $1.11, reflecting strong growth momentum [19][37] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the growth potential in both segments, driven by local leaders' readiness to drive organic and inorganic growth [19] - The company remains confident in its ability to adapt to potential changes in the legislative funding environment, particularly regarding Medicaid [66] Other Important Information - The company completed numerous strategic acquisitions, including the $80 million purchase of Signature Healthcare at Home, enhancing its operational capabilities [13] - The company has a healthy balance sheet with $245.8 million available on its revolving line of credit and $24.2 million in cash on hand at year-end [36] Q&A Session Summary Question: Can you walk us through the expectations for same-store revenue growth for home health, hospice, and senior living within the 2025 guidance? - The company projects about a 7% increase in revenue for same-store operations, excluding Signature [53] Question: How do you assess the legislative funding environment and its impact on your business? - The company noted that 13% of its revenue mix is from Medicaid, primarily in senior living, and expressed optimism about the resilience of its model amid potential funding changes [61][66] Question: What are the expectations for operating cash flow and CapEx for 2025? - The company anticipates mid to high forties for operating cash flow and similar CapEx expenditures as in the previous year [71] Question: How do you expect EBITDA margins to improve with recent acquisitions? - The company expects some impact from recent acquisitions but aims to maintain high EBITDA margins in home health and hospice, while improving senior living margins throughout the year [83][84]